Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Immunoregulating effect of IL-4 in IDDM

Nov. 20, 1996

Pharming granted orphan drug status for Pompe's disease therapy

Nov. 20, 1996

Warner-Lambert claims lipid-regulating agents for vascular disease, diabetes

Nov. 20, 1996

FDA approves treatment for homocystinuria

Nov. 19, 1996

Growth stimulant reported by American Cyanamid

Nov. 19, 1996

Second NDA submitted for Crinone

Nov. 15, 1996

Lilly reports agents to treat menopause-related conditions

Nov. 15, 1996

Vasomax enters pivotal trials

Nov. 15, 1996

PKC inhibitors from Lilly for various therapeutic indications

Nov. 15, 1996

Wyeth-Ayerst withdraws diabetes drug from markets worldwide

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...